Page last updated: 2024-11-04

sulfasalazine and Acquired Hyperostosis Syndrome

sulfasalazine has been researched along with Acquired Hyperostosis Syndrome in 4 studies

Sulfasalazine: A drug that is used in the management of inflammatory bowel diseases. Its activity is generally considered to lie in its metabolic breakdown product, 5-aminosalicylic acid (see MESALAMINE) released in the colon. (From Martindale, The Extra Pharmacopoeia, 30th ed, p907)
sulfasalazine : An azobenzene consisting of diphenyldiazene having a carboxy substituent at the 4-position, a hydroxy substituent at the 3-position and a 2-pyridylaminosulphonyl substituent at the 4'-position.

Acquired Hyperostosis Syndrome: Syndrome consisting of SYNOVITIS; ACNE CONGLOBATA; PALMOPLANTAR PUSTULOSIS; HYPEROSTOSIS; and OSTEITIS. The most common site of the disease is the upper anterior chest wall, characterized by predominantly osteosclerotic lesions, hyperostosis, and arthritis of the adjacent joints. The association of sterile inflammatory bone lesions and neutrophilic skin eruptions is indicative of this syndrome.

Research Excerpts

ExcerptRelevanceReference
"A FREQUENT AFFECTION: Ankylosing spondylitis is a chronic inflammatory rheumatism usually affecting young adults and characterized by an inflammatory enthesiopathy progressing towards ossification and ankylosis."2.42[Ankylosing spondylitis]. ( El Maghraoui, A, 2004)
"Sulfasalazine was used in five patients, to good effect in four."1.31Chronic recurrent multifocal osteomyelitis: five-year outcomes in 14 pediatric cases. ( Job-Deslandre, C; Kahan, A; Krebs, S, 2001)

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (75.00)29.6817
2010's1 (25.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Zhang, LL1
Zhao, JX1
Liu, XY1
El Maghraoui, A1
Rothschild, B1
Schils, J1
Lavelle, H1
Job-Deslandre, C1
Krebs, S1
Kahan, A1

Reviews

1 review available for sulfasalazine and Acquired Hyperostosis Syndrome

ArticleYear
[Ankylosing spondylitis].
    Presse medicale (Paris, France : 1983), 2004, Nov-20, Volume: 33, Issue:20

    Topics: Acquired Hyperostosis Syndrome; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; A

2004

Other Studies

3 other studies available for sulfasalazine and Acquired Hyperostosis Syndrome

ArticleYear
Successful treatment of SAPHO syndrome with severe spinal disorder using entercept: a case study.
    Rheumatology international, 2012, Volume: 32, Issue:7

    Topics: Acquired Hyperostosis Syndrome; Alendronate; Antirheumatic Agents; Bone Density Conservation Agents;

2012
Potential therapeutic approach to SAPHO.
    Seminars in arthritis and rheumatism, 2000, Volume: 29, Issue:5

    Topics: Acquired Hyperostosis Syndrome; Adult; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents

2000
Chronic recurrent multifocal osteomyelitis: five-year outcomes in 14 pediatric cases.
    Joint bone spine, 2001, Volume: 68, Issue:3

    Topics: Acquired Hyperostosis Syndrome; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Bone

2001